Drug
Beta-Carotene
Beta-Carotene is a pharmaceutical drug with 8 clinical trials. Historical success rate of 100.0%.
Total Trials
8
Max Phase
—
Type
DRUG
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 6 completed trials
Completion Rate
100%(6/6)
Active Trials
0(0%)
Results Posted
0%(0 trials)
Phase Distribution
Ph phase_2
1
13%
Ph not_applicable
4
50%
Ph phase_3
3
38%
Phase Distribution
0
Early Stage
1
Mid Stage
3
Late Stage
Phase Distribution8 total trials
Phase 2Efficacy & side effects
1(12.5%)
Phase 3Large-scale testing
3(37.5%)
N/ANon-phased studies
4(50.0%)
Highest Phase Reached
Phase 3Trial Status & Enrollment
Completion Rate
100.0%
6 of 6 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
0
trials recruiting
Total Trials
8
all time
Status Distribution
Completed(6)
Other(2)
Detailed Status
Completed6
unknown2
Development Timeline
Analytics
Development Status
Total Trials
8
Active
0
Success Rate
100.0%
Most Advanced
Phase 3
Trials by Phase
Phase 21 (12.5%)
Phase 33 (37.5%)
N/A4 (50.0%)
Trials by Status
unknown225%
completed675%
Recent Activity
0 active trials
Showing 5 of 8
completedphase_2
Women's Antioxidant and Folic Acid Cardiovascular Study (WAFACS)
NCT00000541
completednot_applicable
Lycopene and Beta-carotene Metabolism in the Digestive Tract of Healthy Men
NCT03492593
completednot_applicable
Physicians' Health Study II
NCT00270647
completedphase_3
Arterial Disease Multifactorial Intervention Trial (ADMIT)
NCT00000539
completednot_applicable
Effect of SNPs in the BCMO1 Enzyme
NCT02276014
Clinical Trials (8)
Showing 8 of 8 trials
NCT00000541Phase 2
Women's Antioxidant and Folic Acid Cardiovascular Study (WAFACS)
NCT03492593Not Applicable
Lycopene and Beta-carotene Metabolism in the Digestive Tract of Healthy Men
NCT00270647Not Applicable
Physicians' Health Study II
NCT00000539Phase 3
Arterial Disease Multifactorial Intervention Trial (ADMIT)
NCT02276014Not Applicable
Effect of SNPs in the BCMO1 Enzyme
NCT01477112Not Applicable
Low Dose β-carotene Supplementation Diminishes Oxidative Stress in Type 2 Diabetics and Healthy Individuals
NCT00000161Phase 3
Randomized Trials of Vitamin Supplements and Eye Disease
NCT00000152Phase 3
Randomized Trial of Beta-Carotene and Macular Degeneration
All 8 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 8